Cerner expands to create 50 new research and development roles

Working with the support of the Irish Government through IDA Ireland, Cerner will create 50 new roles focused on R&D and the improvement of data intelligence and population health management for their European clients.

The new roles initially will focus on developing advanced predictive algorithms to run on their population health intelligence platform, HealtheIntentSM, and help their clients proactively manage health and improve the wellbeing of their communities.

The company said the advancements enable a shift from reactive care to proactive health, supporting health and care professionals to take appropriate preventative actions that can keep patients out of the hospitals, reduce morbidity, and encourage citizens to take ownership over the management of their health.

Speaking about the announcement, Ireland’s Minister for Business, Enterprise & Innovation, Heather Humphreys TD said “I am delighted to see Cerner expand its Dublin operation with the creation of 50 high quality R&D jobs. This is an exciting announcement, which enhances Ireland’s capability in the healthcare IT sector. I wish the company every success in the exciting times ahead.”

Matthew Pickett, Senior Director and General Manager for Cerner Ireland, said: “Cerner have had a permanent presence in Ireland since 2007, supporting our global clients in the transformation of health and care services and the improvement of their populations’ wellbeing. When seeking a European location in which to further build upon Cerner’s rapidly growing capabilities in Population Health Management, the expansion of our existing Dublin team was a natural step.

“Projects resulting from this new investment, supported by IDA Ireland, will enable the delivery of smarter, better care for citizens and healthier populations across the globe.”

Senior Director for Population Health in Europe, Aiden Malone, added:“Population health is about taking responsibility for managing the overall health and wellbeing of a defined population and being accountable for the health outcomes of that population. It’s about how we can move from treating conditions to preventing them from happening in the first place. The expansion of our R&D team in Dublin will allow us to develop new intelligence on our HealtheIntentSM platform and continue to enable the shift to value-based care for populations through delivering outcomes one person at a time.

“We are looking forward to partnering with companies, academic institutions, and the thriving innovation scene in the Irish ecosystem to bring together research and development in areas of medical technology, pharmaceutical, big data & analytics, advanced technology and the focus area of IoT. These elements are key components of delivering Population Health Management and will have a direct impact on improving outcomes of millions of lives.”